Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in

Réka Bodea1, Toader Septimiu Voidăzan1, Lorand Iozsef Ferencz2

  • 1Department of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mureș, 540142 Târgu Mureș, Romania.

Microorganisms
|April 26, 2025
PubMed

Insights

Hospitalized patients with comorbidities in Central Romania faced severe COVID-19 outcomes. Pre-existing conditions like renal and cardiovascular disease significantly increased mortality risk, highlighting the need for targeted interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Internal Medicine

Background:

  • The COVID-19 pandemic caused a global health crisis, with severe disease disproportionately affecting individuals with pre-existing medical conditions (comorbidities).
  • Understanding the impact of comorbidities on COVID-19 outcomes in specific regions is crucial for effective public health strategies.

Purpose of the Study:

  • To determine the prevalence of severe COVID-19 among hospitalized patients with comorbidities in Central Romania.
  • To analyze the association between specific comorbidities and mortality in SARS-CoV-2 infected patients.

Main Methods:

  • Retrospective cohort study utilizing data from the Corona Forms platform (2020-2022).
  • Inclusion of 1458 hospitalized patients with confirmed SARS-CoV-2 infection and documented comorbidities across three Romanian counties.
  • Analysis of demographic characteristics, comorbid conditions, and hospitalization outcomes, including mortality.

Main Results:

  • The overall mortality rate among hospitalized patients with comorbidities was 89.3%.
  • Significant risk factors for mortality included renal disease, neurologic disease, hepatic disease, cardiovascular conditions, obesity, type 2 diabetes mellitus, and cerebrovascular accidents.
  • Odds ratios for mortality associated with these conditions ranged from 1 to 25.32.

Conclusions:

  • Comorbidities have a critical impact on COVID-19 severity and mortality in the Central Romanian population.
  • Targeted clinical interventions and public health strategies are essential to protect high-risk populations with pre-existing conditions.
  • The study underscores the vulnerability of patients with multiple health issues during the COVID-19 pandemic.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
117
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
173
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
145
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
129
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.6K